Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow-to-Debt Ratio
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow-to-Debt Ratio of -0.11x as of June 2025, meaning its operating cash flow of ₩-15.17 Billion could theoretically repay 0% of its total liabilities (₩142.34 Billion) in one year. See cash generation quality of Sam Chun Dang Pharm. Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Sam Chun Dang Pharm. Co. Ltd across 13 annual periods. Also explore how fast is Sam Chun Dang Pharm. Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for Sam Chun Dang Pharm. Co. Ltd. For market capitalisation and broader financial context, see Sam Chun Dang Pharm. Co. Ltd (000250) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩21.77 Billion | ₩253.67 Billion | ▼ -59.9% |
| 2023 | 0.21x | ₩23.43 Billion | ₩109.56 Billion | ▲ +220.5% |
| 2022 | 0.07x | ₩13.28 Billion | ₩199.05 Billion | ▲ +248.8% |
| 2021 | -0.04x | ₩-7.71 Billion | ₩171.90 Billion | ▼ -280.0% |
| 2020 | 0.02x | ₩3.25 Billion | ₩130.45 Billion | ▼ -89.2% |
| 2019 | 0.23x | ₩30.60 Billion | ₩132.28 Billion | ▲ +4.1% |
| 2018 | 0.22x | ₩25.03 Billion | ₩112.64 Billion | ▼ -24.3% |
| 2017 | 0.29x | ₩26.09 Billion | ₩88.80 Billion | ▲ +32.2% |
| 2016 | 0.22x | ₩17.76 Billion | ₩79.95 Billion | ▼ -10.4% |
| 2015 | 0.25x | ₩17.34 Billion | ₩69.94 Billion | ▼ -58.4% |
| 2014 | 0.60x | ₩19.55 Billion | ₩32.81 Billion | ▲ +35.1% |
| 2013 | 0.44x | ₩15.94 Billion | ₩36.15 Billion | ▲ +875.6% |
| 2012 | 0.05x | ₩1.60 Billion | ₩35.44 Billion | — |